273 related articles for article (PubMed ID: 16418824)
1. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction.
Takano H; Qin Y; Hasegawa H; Ueda K; Niitsuma Y; Ohtsuka M; Komuro I
J Mol Med (Berl); 2006 Mar; 84(3):185-93. PubMed ID: 16418824
[TBL] [Abstract][Full Text] [Related]
2. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
Harada M; Qin Y; Takano H; Minamino T; Zou Y; Toko H; Ohtsuka M; Matsuura K; Sano M; Nishi J; Iwanaga K; Akazawa H; Kunieda T; Zhu W; Hasegawa H; Kunisada K; Nagai T; Nakaya H; Yamauchi-Takihara K; Komuro I
Nat Med; 2005 Mar; 11(3):305-11. PubMed ID: 15723072
[TBL] [Abstract][Full Text] [Related]
3. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
[TBL] [Abstract][Full Text] [Related]
4. G-CSF therapy for acute myocardial infarction.
Takano H; Ueda K; Hasegawa H; Komuro I
Trends Pharmacol Sci; 2007 Oct; 28(10):512-7. PubMed ID: 17888521
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction.
Takano H; Ohtsuka M; Akazawa H; Toko H; Harada M; Hasegawa H; Nagai T; Komuro I
Curr Pharm Des; 2003; 9(14):1121-7. PubMed ID: 12769752
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.
Okada H; Takemura G; Kosai K; Tsujimoto A; Esaki M; Takahashi T; Nagano S; Kanamori H; Miyata S; Li Y; Ohno T; Maruyama R; Ogino A; Li L; Nakagawa M; Nagashima K; Fujiwara T; Fujiwara H; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H616-26. PubMed ID: 19151252
[TBL] [Abstract][Full Text] [Related]
7. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
[TBL] [Abstract][Full Text] [Related]
8. G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?
Shim W; Mehta A; Lim SY; Zhang G; Lim CH; Chua T; Wong P
Cardiovasc Res; 2011 Jan; 89(1):20-30. PubMed ID: 20851808
[TBL] [Abstract][Full Text] [Related]
9. Future investigations in stem cell activation with granulocyte-colony-stimulating factor after myocardial infarction.
Ince H; Nienaber CA
Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S119-22. PubMed ID: 17230209
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway.
Ueda K; Takano H; Hasegawa H; Niitsuma Y; Qin Y; Ohtsuka M; Komuro I
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):e108-13. PubMed ID: 16574892
[TBL] [Abstract][Full Text] [Related]
11. G-CSF-based stem cell therapy for the heart-unresolved issues part A: paracrine actions, mobilization, and delivery.
Kurdi M; Booz GW
Congest Heart Fail; 2007; 13(4):221-7. PubMed ID: 17673875
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor attenuates myocardial remodeling and ventricular arrhythmia susceptibility via the JAK2-STAT3 pathway in a rabbit model of coronary microembolization.
Wang W; Ye S; Zhang L; Jiang Q; Chen J; Chen X; Zhang F; Wu H
BMC Cardiovasc Disord; 2020 Feb; 20(1):85. PubMed ID: 32066388
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
14. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling.
Lehrke S; Mazhari R; Durand DJ; Zheng M; Bedja D; Zimmet JM; Schuleri KH; Chi AS; Gabrielson KL; Hare JM
Circ Res; 2006 Sep; 99(5):553-60. PubMed ID: 16873716
[TBL] [Abstract][Full Text] [Related]
15. Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans.
Nienaber CA; Petzsch M; Kleine HD; Eckard H; Freund M; Ince H
Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S73-7. PubMed ID: 16501636
[TBL] [Abstract][Full Text] [Related]
16. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis.
Kuhlmann MT; Kirchhof P; Klocke R; Hasib L; Stypmann J; Fabritz L; Stelljes M; Tian W; Zwiener M; Mueller M; Kienast J; Breithardt G; Nikol S
J Exp Med; 2006 Jan; 203(1):87-97. PubMed ID: 16401694
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
[TBL] [Abstract][Full Text] [Related]
18. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI).
Ince H; Petzsch M; Kleine HD; Schmidt H; Rehders T; Körber T; Schümichen C; Freund M; Nienaber CA
Circulation; 2005 Nov; 112(20):3097-106. PubMed ID: 16275869
[TBL] [Abstract][Full Text] [Related]
19. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A;
JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
